Strides Pharma develops Favipiravir antiviral tablets; drug shows positive outcome in COVID-19 treatment

Strides Pharma Science Ltd on Wednesday said it has developed and
commercialised Favipiravir antiviral tablets and stressed that the
drug has demonstrated positive outcomes in COVID-19 treatment
globally.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-pharma-develops-favipiravir-antiviral-tablets-drug-shows-positive-outcome-in-covid-19-treatment/articleshow/75445430.cms

Comments

Popular posts from this blog

Clinical Database Management Professional Vacancy @ Teva

Pharma Production Executive Post Vacancy @ Intas

Biotecnika Times – Newsletter 28.02.2020 – DST Women Scientist WOS B, DBT-IOC Recruitment